IL17RA and familial pancreatic carcinoma: The percentage of effector memory T population in CD4+CD3+IL-17R+ (Figure 4D) and CD8+CD3+IL-17R+ (Figure 4E) population appears to be higher in pancreatic cancer patients compared to other disease group whilst the percentage of naive T cells in pancreatic cancer patients tends to be decreased in both CD4+CD3+IL-17R+ (Figure 4D) and CD8+CD3+IL-17R+ (Figure 4E) cells.